TSX-18110-71752
4 vaccinations
1 coded response
22 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 283 / NC
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Dose 1 — Moderna
-
2021-03-26
Registered in v-safe
-
2021-03-26
Dose 2 — Moderna
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-06-25
- 2021-09-26
-
2021-12-10
Dose 3 — Moderna
- 2022-03-29
-
2022-11-13
Dose 4 — ModernaCo-administered: Flu
- 2022-11-28
- 2022-12-04
- 2022-12-11
- 2022-12-18
- 2023-02-13
-
2023-05-21
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Moderna | |
| 2 | 2021-03-26 | Moderna | |
| 3 | 2021-12-10 | Moderna | No |
| 4 | 2022-11-13 | Moderna | Flu |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release